X-ray interactions: photoabsorption, scattering, transmission, and reflection at E= 50-30,000 eV, Z= 1-92

BL Henke, EM Gullikson, JC Davis - Atomic data and nuclear data tables, 1993 - Elsevier
The primary interactions of low-energy x-rays within condensed matter, viz. photoabsorption
and coherent scattering, have been described for photon energies outside the absorption …

[BOOK][B] Statistics and data analysis in geology

JC Davis, RJ Sampson - 1986 - kgs.ku.edu
Because the notation used in this section (Eqs. 4.80 through 4.84) is inconsistent with that
used elsewhere in the book, it may be confusing. This confusion can be resolved by some …

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

, … C 3 Evans David M davide@ well. ox. ac. uk 3 c … - Nature …, 2007 - nature.com
We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility
complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), …

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double‐blind, placebo‐controlled trial

…, RL Wong, H Kupper, JC Davis Jr - … : Official Journal of …, 2006 - Wiley Online Library
Objective To evaluate the safety and efficacy of adalimumab, a fully human recombinant IgG1
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …

[HTML][HTML] Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α

JD Gorman, KE Sack, JC Davis Jr - New England Journal of …, 2002 - Mass Medical Soc
Background There are few effective treatments for ankylosing spondylitis, which causes
substantial morbidity. Because of the central role of tumor necrosis factor α in the …

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

JC Davis Jr, D Van Der Heijde, J Braun… - Arthritis & …, 2003 - Wiley Online Library
Objective To determine the safety and efficacy of etanercept in a multicenter, randomized,
placebo‐controlled, double‐blind trial of adults with moderate to severe active ankylosing …

ASAS/EULAR recommendations for the management of ankylosing spondylitis

…, R Burgos-Vargas, E Collantes, JC Davis… - Annals of the …, 2006 - ard.bmj.com
Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the ‘ASsessment in AS’ international working group …

Using multiple logistic regression and GIS technology to predict landslide hazard in northeast Kansas, USA

GC Ohlmacher, JC Davis - Engineering geology, 2003 - Elsevier
Landslides in the hilly terrain along the Kansas and Missouri rivers in northeastern Kansas
have caused millions of dollars in property damage during the last decade. To address this …

Minimal dissolved oxygen requirements of aquatic life with emphasis on Canadian species: a review

JC Davis - Journal of the Fisheries Board of Canada, 1975 - cdnsciencepub.com
This article reviews the sensitivity, responses, response thresholds, and minimum oxygen
requirements of marine and freshwater organisms with strong emphasis on Canadian species. …

Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double‐blind, placebo‐controlled, phase III trial

RD Inman, JC Davis Jr, DVD Heijde… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing
spondylitis (AS) in the GO‐RAISE study. Methods Patients with active AS, a Bath AS Disease …